|
|
Article: Senate Passes BioShield In 99-0 Vote; $5.6B Slated For Industry.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
WASHINGTON - With bipartisan support from the likes of Sens. Bill Frist and Ted Kennedy, Project BioShield on Wednesday passed the Senate in a 99-0 vote.
If signed into law by President Bush in the next few weeks, BioShield would flood the industry with $5.6 billion over the next decade for the procurement of vaccines against chemical, biological, nuclear or radiological attacks. The federal budget for 2004 allocates $890 million to the project.
Products under consideration for BioShield are a recombinant protective antigen (rPA) anthrax vaccine, anthrax therapeutics, a next-generation smallpox vaccine, antitoxins to botulinum ...